Hussman Strategic Advisors’s Usana Health Sciences USNA Stock Holding History

Hussman Strategic Advisors’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-26,000	Closed	-$1.38M	–	347
2022 Q4	$1.38M	Hold	26,000	–	–	0.23%	168
2022 Q3	$1.46M	Hold	26,000	–	–	0.25%	167
2022 Q2	$1.88M	Hold	26,000	–	–	0.32%	112
2022 Q1	$2.07M	Buy	26,000 +1,200	+5%	+$108K	0.4%	91
2021 Q4	$2.51M	Hold	24,800	–	–	0.55%	57
2021 Q3	$2.29M	Buy	24,800 +10,400	+72%	+$1M	0.5%	66
2021 Q2	$1.48M	Hold	14,400	–	–	0.31%	134
2021 Q1	$1.41M	Sell	14,400 -11,100	-44%	-$1.01M	0.29%	132
2020 Q4	$1.97M	Hold	25,500	–	–	0.52%	74
2020 Q3	$1.88M	Buy	+25,500	New	+$2.05M	0.5%	69
2018 Q2	–	Sell	-35,000	Closed	-$3.01M	–	254
2018 Q1	$3.01M	Buy	+35,000	New	+$2.71M	0.83%	49

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Hussman Strategic Advisors's USNA Position: Q1 2023 in Review

Hussman Strategic Advisors sold out of Usana Health Sciences (USNA) in Q1 2023, closing a stake of 26,000 shares — an estimated $1.38M sold.

Hussman Strategic Advisors first reported a position in USNA in Q1 2018 and held it in 11 quarters. The position peaked at $3.01M in Q1 2018. 176 funds tracked by Wall St. Rank hold USNA as of Q1 2023.

Hussman Strategic Advisors reported no remaining Usana Health Sciences position as of Q1 2023 after selling out during the quarter.
Hussman Strategic Advisors sold 26,000 Usana Health Sciences shares in Q1 2023, an estimated $1.38M.
Hussman Strategic Advisors first reported a position in Usana Health Sciences in Q1 2018 and held it in 11 quarters.
Hussman Strategic Advisors's Usana Health Sciences position peaked at $3.01M in Q1 2018.
176 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2023.

Based on Hussman Strategic Advisors's 13F filing for Q1 2023, filed 5 May 2023.